ANDA 75206, held by Teva Pharms USA. Cytarabine.
As of Nov 16, 2026, ANDA 75206 (Cytosar-U), held by Teva Pharms USA, was first approved by FDA on Dec 30, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 30, 1998 | Original application | Approved | None posted |
| Cytosar-U100MG/VIAL · injectable;injection | Cytarabine | Discontinued |
| Cytosar-U500MG/VIAL · injectable;injection | Cytarabine | Discontinued |
| Cytosar-U2GM/VIAL · injectable;injection | Cytarabine | Discontinued |
| Cytosar-U1GM/VIAL · injectable;injection | Cytarabine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters